183 related articles for article (PubMed ID: 27012860)
21. Restoring the activity of the antibiotic aztreonam using the polyphenol epigallocatechin gallate (EGCG) against multidrug-resistant clinical isolates of
Betts JW; Hornsey M; Higgins PG; Lucassen K; Wille J; Salguero FJ; Seifert H; La Ragione RM
J Med Microbiol; 2019 Oct; 68(10):1552-1559. PubMed ID: 31419210
[No Abstract] [Full Text] [Related]
22. Demonstration of the efficacy of curcumin on carbapenem-resistant Pseudomonas aeruginosa with Galleria mellonella larvae model.
Ozturk S
Arch Microbiol; 2022 Jul; 204(8):524. PubMed ID: 35882691
[TBL] [Abstract][Full Text] [Related]
23. A comparative study on the effect of algal and fish oil on viability and cell proliferation of Caco-2 cells.
van Beelen VA; Roeleveld J; Mooibroek H; Sijtsma L; Bino RJ; Bosch D; Rietjens IM; Alink GM
Food Chem Toxicol; 2007 May; 45(5):716-24. PubMed ID: 17141934
[TBL] [Abstract][Full Text] [Related]
24. Assessing phage therapy against Pseudomonas aeruginosa using a Galleria mellonella infection model.
Beeton ML; Alves DR; Enright MC; Jenkins AT
Int J Antimicrob Agents; 2015 Aug; 46(2):196-200. PubMed ID: 26100212
[TBL] [Abstract][Full Text] [Related]
25. Healthy effect of different proportions of marine ω-3 PUFAs EPA and DHA supplementation in Wistar rats: Lipidomic biomarkers of oxidative stress and inflammation.
Dasilva G; Pazos M; García-Egido E; Gallardo JM; Rodríguez I; Cela R; Medina I
J Nutr Biochem; 2015 Nov; 26(11):1385-92. PubMed ID: 26320676
[TBL] [Abstract][Full Text] [Related]
26. Rhesus θ-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosa.
Beringer PM; Bensman TJ; Ho H; Agnello M; Denovel N; Nguyen A; Wong-Beringer A; She R; Tran DQ; Moskowitz SM; Selsted ME
J Antimicrob Chemother; 2016 Jan; 71(1):181-8. PubMed ID: 26433781
[TBL] [Abstract][Full Text] [Related]
27. Clinafloxacin for Treatment of Burkholderia cenocepacia Infection in a Cystic Fibrosis Patient.
Balwan A; Nicolau DP; Wungwattana M; Zuckerman JB; Waters V
Antimicrob Agents Chemother; 2016 Jan; 60(1):1-5. PubMed ID: 26722110
[TBL] [Abstract][Full Text] [Related]
28. Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection.
Govan JR; Brown AR; Jones AM
Future Microbiol; 2007 Apr; 2(2):153-64. PubMed ID: 17661652
[TBL] [Abstract][Full Text] [Related]
29. Bioavailability of fatty acids from krill oil, krill meal and fish oil in healthy subjects--a randomized, single-dose, cross-over trial.
Köhler A; Sarkkinen E; Tapola N; Niskanen T; Bruheim I
Lipids Health Dis; 2015 Mar; 14():19. PubMed ID: 25884846
[TBL] [Abstract][Full Text] [Related]
30. Topical Formulation Comprising Fatty Acid Extract from Cod Liver Oil: Development, Evaluation and Stability Studies.
Ilievska B; Loftsson T; Hjalmarsdottir MA; Asgrimsdottir GM
Mar Drugs; 2016 Jun; 14(6):. PubMed ID: 27258290
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients.
Olszak T; Zarnowiec P; Kaca W; Danis-Wlodarczyk K; Augustyniak D; Drevinek P; de Soyza A; McClean S; Drulis-Kawa Z
Appl Microbiol Biotechnol; 2015 Jul; 99(14):6021-33. PubMed ID: 25758956
[TBL] [Abstract][Full Text] [Related]
32. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
[TBL] [Abstract][Full Text] [Related]
33. Using Small-Molecule Adjuvants to Repurpose Azithromycin for Use against Pseudomonas aeruginosa.
Hubble VB; Hubbard BA; Minrovic BM; Melander RJ; Melander C
ACS Infect Dis; 2019 Jan; 5(1):141-151. PubMed ID: 30444345
[TBL] [Abstract][Full Text] [Related]
34. Experimental bacteriophage therapy increases survival of Galleria mellonella larvae infected with clinically relevant strains of the Burkholderia cepacia complex.
Seed KD; Dennis JJ
Antimicrob Agents Chemother; 2009 May; 53(5):2205-8. PubMed ID: 19223640
[TBL] [Abstract][Full Text] [Related]
35. Variation of Burkholderia cenocepacia virulence potential during cystic fibrosis chronic lung infection.
Moreira AS; Mil-Homens D; Sousa SA; Coutinho CP; Pinto-de-Oliveira A; Ramos CG; Dos Santos SC; Fialho AM; Leitão JH; Sá-Correia I
Virulence; 2017 Aug; 8(6):782-796. PubMed ID: 27652671
[TBL] [Abstract][Full Text] [Related]
36. Belfast Agar-a simple laboratory medium to separate Pseudomonas aeruginosa from pan-resistant Burkholderia cenocepacia isolated from the sputum of patients with cystic fibrosis (CF).
Caskey S; Moore JE; McCaughan J; Rendall JC
Br J Biomed Sci; 2018 Apr; 75(2):101-103. PubMed ID: 29513134
[No Abstract] [Full Text] [Related]
37. Estimating in vivo airway surface liquid concentration in trials of inhaled antibiotics.
Hasan MA; Lange CF
J Aerosol Med; 2007; 20(3):282-93. PubMed ID: 17894535
[TBL] [Abstract][Full Text] [Related]
38. Marine and freshwater fish oil varying in arachidonic, eicosapentaenoic and docosahexaenoic acids differ in their effects on organ lipids and fatty acids in growing rats.
Innis SM; Rioux FM; Auestad N; Ackman RG
J Nutr; 1995 Sep; 125(9):2286-93. PubMed ID: 7666244
[TBL] [Abstract][Full Text] [Related]
39. Vitamin E Increases Antimicrobial Sensitivity by Inhibiting Bacterial Lipocalin Antibiotic Binding.
Naguib MM; Valvano MA
mSphere; 2018 Dec; 3(6):. PubMed ID: 30541778
[No Abstract] [Full Text] [Related]
40. Fish oil attenuates persistent inflammatory pain in rats through modulation of TNF-α and resolvins.
Lobo BW; Lima CK; Teixeira MS; Silva NL; Takiya CM; Ramos MF; Miranda AL; Dellamora-Ortiz GM
Life Sci; 2016 May; 152():30-7. PubMed ID: 27012767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
